Colonization of the intestinal tract of conventional mice with Candida albicans and treatment with antifungal agents
- PMID: 782356
- PMCID: PMC429622
- DOI: 10.1128/AAC.9.5.787
Colonization of the intestinal tract of conventional mice with Candida albicans and treatment with antifungal agents
Abstract
Conventional mice inoculated with Candida albicans per os were unable to maintain this organism in the intestinal tract as judged by decreasing numbers of yeast recoverable from feces. After inoculation with 10(7) cells/mouse, fecal counts ranged from 10(5) cells per g of feces to 5 x 10(3) cells per g of feces during a 12-day experimental period. Addition of various antibiotics to the drinking water did not result in any improvement in maintenance or stability of the gut population. A combination of X irradiation and administration of tobramycin or gentamicin, however, resulted in a stable population of C. albicans in the intestinal tract, with cell counts in the feces remaining constant at a level of about 10(6)/g of feces for a period of 10 to 15 days. The usefulness of this model in assessing the effect of experimental drugs on C. albicans infections of the gut was demonstrated by the fact that treatment with a new antifungal antibiotic (A9145), amphotericin B, 5-fluorocytosine, or nystatin resulted in a reduction in the fecal counts of C. albicans from experimentally infected animals.
Similar articles
-
New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents.Antimicrob Agents Chemother. 1996 Jul;40(7):1604-9. doi: 10.1128/AAC.40.7.1604. Antimicrob Agents Chemother. 1996. PMID: 8807048 Free PMC article.
-
An anaerobic continuous-flow culture model of interactions between intestinal microflora and Candida albicans.Mycopathologia. 1988 Sep;103(3):125-34. doi: 10.1007/BF00436810. Mycopathologia. 1988. PMID: 3057377
-
Study on the comparative activity of echinocandins on murine gut colonization by Candida albicans.Med Mycol. 2015 Aug;53(6):597-602. doi: 10.1093/mmy/myv028. Epub 2015 May 14. Med Mycol. 2015. PMID: 25980001
-
Candida albicans gastrointestinal colonization and invasion in the mouse: effect of antibacterial dosing, antifungal therapy and immunosuppression.Mycoses. 1989 Dec;32(12):664-74. doi: 10.1111/j.1439-0507.1989.tb02199.x. Mycoses. 1989. PMID: 2695843
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
Cited by
-
Mice with persistent gastrointestinal Candida albicans as a model for antifungal therapy.Antimicrob Agents Chemother. 1982 Jan;21(1):51-3. doi: 10.1128/AAC.21.1.51. Antimicrob Agents Chemother. 1982. PMID: 7044301 Free PMC article.
-
Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.Eur J Epidemiol. 1992 May;8(3):477-83. doi: 10.1007/BF00158585. Eur J Epidemiol. 1992. PMID: 1397212 No abstract available.
-
A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia.Med Mycol. 2009 Mar;47(2):157-67. doi: 10.1080/13693780802165797. Epub 2008 Jun 10. Med Mycol. 2009. PMID: 18608888 Free PMC article.
-
Persistence and spread of Candida albicans after intragastric inoculation of infant mice.Infect Immun. 1981 Feb;31(2):783-91. doi: 10.1128/iai.31.2.783-791.1981. Infect Immun. 1981. PMID: 7012021 Free PMC article.
-
A model of sustained gastrointestinal colonization by Candida albicans in healthy adult mice.Infect Immun. 1990 Jun;58(6):1514-7. doi: 10.1128/iai.58.6.1514-1517.1990. Infect Immun. 1990. PMID: 2187800 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources